| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |